Borchmann, P., Plütschow, A., Kobe, C., Greil, R., Meißner, J., Topp, M. S., . . . Engert, A. (2021). PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): A multicentre, open-label, randomised, phase 3 trial. The lancet. Oncology, 22(2), . https://doi.org/10.1016/S1470-2045(20)30601-X
Chicago-Zitierstil (17. Ausg.)Borchmann, Peter, et al. "PET-guided Omission of Radiotherapy in Early-stage Unfavourable Hodgkin Lymphoma (GHSG HD17): A Multicentre, Open-label, Randomised, Phase 3 Trial." The Lancet. Oncology 22, no. 2 (2021). https://doi.org/10.1016/S1470-2045(20)30601-X.
MLA-Zitierstil (9. Ausg.)Borchmann, Peter, et al. "PET-guided Omission of Radiotherapy in Early-stage Unfavourable Hodgkin Lymphoma (GHSG HD17): A Multicentre, Open-label, Randomised, Phase 3 Trial." The Lancet. Oncology, vol. 22, no. 2, 2021, https://doi.org/10.1016/S1470-2045(20)30601-X.